ZA853759B - Tetrahydronaphthalenols for the treatment of hypertension - Google Patents

Tetrahydronaphthalenols for the treatment of hypertension

Info

Publication number
ZA853759B
ZA853759B ZA853759A ZA853759A ZA853759B ZA 853759 B ZA853759 B ZA 853759B ZA 853759 A ZA853759 A ZA 853759A ZA 853759 A ZA853759 A ZA 853759A ZA 853759 B ZA853759 B ZA 853759B
Authority
ZA
South Africa
Prior art keywords
tetrahydronaphthalenols
hypertension
treatment
Prior art date
Application number
ZA853759A
Other languages
English (en)
Inventor
Karnail Singh Atwal
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA853759B publication Critical patent/ZA853759B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
ZA853759A 1984-05-17 1985-05-17 Tetrahydronaphthalenols for the treatment of hypertension ZA853759B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61125884A 1984-05-17 1984-05-17

Publications (1)

Publication Number Publication Date
ZA853759B true ZA853759B (en) 1986-01-29

Family

ID=24448300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA853759A ZA853759B (en) 1984-05-17 1985-05-17 Tetrahydronaphthalenols for the treatment of hypertension

Country Status (13)

Country Link
EP (1) EP0163458A1 (ja)
JP (1) JPS60260546A (ja)
KR (1) KR910002944B1 (ja)
AU (1) AU573828B2 (ja)
DK (1) DK219885A (ja)
ES (2) ES8701144A1 (ja)
FI (1) FI851969L (ja)
GR (1) GR851204B (ja)
HU (1) HUT38298A (ja)
IL (1) IL75224A (ja)
NZ (1) NZ212112A (ja)
PT (1) PT80481B (ja)
ZA (1) ZA853759B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3765206D1 (de) * 1986-07-28 1990-10-31 Whitby Research Inc Substituierte 2-aminotetraline.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930022A (en) * 1972-07-03 1975-12-30 Squibb & Sons Inc Certain tetrahydronaphthalenes used in the treatment of cardiac arrhythmia
US4267373A (en) * 1972-07-03 1981-05-12 E. R. Squibb & Sons, Inc. 5,6,7,8-Tetrahydronaphthalene hypotensive agents
GB1442851A (en) * 1973-07-09 1976-07-14 Squibb & Sons Inc Substituted cyclic polymethylene phenols
AU8194275A (en) * 1974-06-17 1976-12-16 Takeda Chemical Industries Ltd Aminotetralin compounds
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
NZ213651A (en) * 1984-10-11 1989-07-27 Hoffmann La Roche Tetrahydronapthalene derivatives and medicaments

Also Published As

Publication number Publication date
JPS60260546A (ja) 1985-12-23
DK219885D0 (da) 1985-05-17
HUT38298A (en) 1986-05-28
GR851204B (ja) 1985-11-25
FI851969L (fi) 1985-11-18
KR850008659A (ko) 1985-12-21
EP0163458A1 (en) 1985-12-04
FI851969A0 (fi) 1985-05-17
AU4254785A (en) 1985-11-21
PT80481A (en) 1985-06-01
ES8705363A1 (es) 1987-05-01
ES543242A0 (es) 1986-11-16
ES552087A0 (es) 1987-05-01
KR910002944B1 (ko) 1991-05-11
ES8701144A1 (es) 1986-11-16
DK219885A (da) 1985-11-18
NZ212112A (en) 1988-10-28
PT80481B (en) 1987-01-15
AU573828B2 (en) 1988-06-23
IL75224A0 (en) 1985-09-29
IL75224A (en) 1988-11-15

Similar Documents

Publication Publication Date Title
DE3565482D1 (en) The manufacture of camshafts
DE3565695D1 (en) Process for the treatment of aluminium surfaces
ZA853258B (en) Effluent treatment
GB8430581D0 (en) Treatment
GB8419516D0 (en) Treatment
GB8419515D0 (en) Treatment
ZA857081B (en) Composition for the treatment of allergy
PH22351A (en) Novel method for the treatment of neoplasms
GB8527296D0 (en) Treating slurry
GB8428251D0 (en) Treating aluminium
GB8412049D0 (en) Treatment
GB8418430D0 (en) Treatment
DE3568700D1 (en) Anti-ulcer means for the treatment of abscesses
DE3560035D1 (en) Process for the preparation of 2-methyl-2-alkenals
ZA852638B (en) Oxindole compounds for the treatment of epilepsy
PT79823B (en) Process for the preparation of n-(naphtyl-alquil)-hydroxilamines
GB8428722D0 (en) Treatment of pipelines
PT80481A (en) Tetrahydronaphthalenols for the treatment of hypertension
DE3566249D1 (en) Process for the preparation of fluoroformiates
GB8521996D0 (en) Treatment of structure
GB8422924D0 (en) Prevention of hypertension
EP0186374A3 (en) Process for the copolymerization of propylene
ZA853602B (en) Method for the treatment of neoplasms
ZA824973B (en) Hypertension treatment
EP0190219A4 (en) COMPOSITION FOR TREATING HAEMORRHOIDS.